Dotti Patch, Extended Release
NDC 72162-2034
Product Information
Dotti (estradiol) is a ANDA-approved product labeled by Bryant Ranch Prepack. This medication is a female hormone (estrogen). It is supplied as a patch, extended release for transdermal administration. This product entry covers the primary NDC 72162-2034 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 72162-2034?
What are the uses of this product?
What are Active Ingredients of this product?
- ESTRADIOL .05 mg/d - The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ESTRADIOL (UNII: 4TI98Z838E)
- ESTRADIOL (UNII: 4TI98Z838E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S) (UNII: 83D19O7250)
- OLEYL ALCOHOL (UNII: 172F2WN8DV)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- DIPROPYLENE GLYCOL (UNII: E107L85C40)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2110780 - DOTTI 0.05 MG/Day Twice Weekly Transdermal System
- RxCUI: 2110780 - 84 HR estradiol 0.00208 MG/HR Transdermal System [Dotti]
- RxCUI: 2110780 - 84 HR Dotti 0.00208 MG/HR Transdermal System
- RxCUI: 2110780 - Dotti 0.05 MG/24HR Twice Weekly Transdermal System
- RxCUI: 242891 - estradiol 0.05 MG/Day Twice Weekly Transdermal System
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.